Molecular Pathology of Thyroid Tumors: Old Problems and New Concepts

Area of Science:

• Endocrinology
• Oncology
• Molecular Pathology

Background:

• Thyroid tumor classification has historically relied on histopathology.
• Recent advances in molecular biology have begun to refine diagnostic criteria.
• Understanding the molecular landscape is crucial for targeted therapies.

Purpose of the Study:

• To review recent molecular discoveries in thyroid tumors.
• To emphasize the clinical impact of molecular insights on diagnosis and classification.
• To discuss the role of molecular alterations in rare and aggressive thyroid cancers.

Main Methods:

• Review of recent scientific literature on thyroid tumor molecular pathology.
• Analysis of studies focusing on RAS mutant nodules, Hürthle cell neoplasms, and rare tumor types.
• Discussion of immunohistochemistry for detecting actionable molecular alterations.

Main Results:

• Molecular signatures are increasingly integrated into thyroid tumor diagnostics.
• Specific molecular insights are changing the understanding of RAS mutant nodules and Hürthle cell neoplasms.
• Rare thyroid tumors like hyalinizing trabecular tumor and secretory carcinoma show distinct molecular profiles.
• Immunohistochemistry is valuable for identifying actionable targets in advanced thyroid cancer.

Conclusions:

• Molecular pathology is transforming thyroid cancer diagnosis and classification.
• Targeted therapies are becoming more feasible with the identification of actionable molecular alterations.
• Continued research into molecular signatures will further refine patient management and treatment strategies.